BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 309 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $80,537,000 | +98.9% | 679,238 | +131.2% | 0.42% | +99.1% |
| Q4 2021 | $40,495,000 | -2.5% | 293,843 | -1.7% | 0.21% | -6.6% |
| Q3 2021 | $41,536,000 | +66.3% | 299,014 | +16.2% | 0.23% | +60.3% |
| Q2 2021 | $24,976,000 | -6.7% | 257,264 | -17.6% | 0.14% | -16.6% |
| Q4 2020 | $26,775,000 | +352.9% | 312,393 | +286.3% | 0.17% | +225.0% |
| Q2 2020 | $5,912,000 | -85.5% | 80,865 | -93.2% | 0.05% | -88.1% |
| Q1 2020 | $40,675,000 | – | 1,195,256 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |